Trial Profile

A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Feb 2023 Status changed from active, no longer recruiting to completed.
07 Jun 2022 Results of an exploratory analysis assessing Deficit accumulation frailty index scores and exploring their relationship with treatment outcomes for older AML patients using data from two clinical studies: Alliance/CALGB 11001 and Alliance/CALGB 11002 presented at the 58th Annual Meeting of the American Society of Clinical Oncology
28 Apr 2015 Planned primary completion date changed from 1 May 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com